Loading...
Engineering the biomolecular corona could unlock the clinical potential of lipid nanoparticles for targeted, personalized nanomedicines beyond mRNA vaccines.
1003 Bishop St, Suite 1700 Honolulu, HI 96813, United States
You received this email because you signed up on our website.
© 2024